DISCOVER A DEEPER YOU
DEAD

Serial Number

87295178

Owner

PathoBiome LLC

Attorney

Brian E. Turung

Filing Date

Jan 10, 2017

Add to watchlist:

No watchlists yet
View on USPTO

DISCOVER A DEEPER YOU Trademark

Serial Number: 87295178

DISCOVER A DEEPER YOU is a trademark filed by PathoBiome LLC on January 10, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

PathoBiome LLC (23 trademarks)

Suite 4500
Cleveland, OH 44115

Entity Type: 16

Trademark Details

Filing Date

January 10, 2017

Registration Date

Not Registered

Published for Opposition

November 28, 2017

Goods & Services

Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; nutritional supplements, namely, probiotic compositions; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as crohn's disease, ulcerative colitis and irritable bowel syndrome

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Feb 25, 2019 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 25, 2019 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 24, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jul 20, 2018 EX1G
SOU EXTENSION 1 FILED
Jul 20, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 20, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 23, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 28, 2017 NPUB
PUBLISHED FOR OPPOSITION
Nov 28, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 8, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 12, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 20, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2017 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2017 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 21, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2017 NWOS